Related references
Note: Only part of the references are listed.Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis
Philip A. Guadagno et al.
CLINICA CHIMICA ACTA (2015)
Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population
Sang-Ho Park et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease
Sung Woo Kwon et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
Sotirios Tsimikas et al.
LANCET (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting
Marat V. Ezhov et al.
ATHEROSCLEROSIS (2014)
Lipoprotein(a) There's Life in the Old Dog Yet
Florian Kronenberg
CIRCULATION (2014)
Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Amit V. Khera et al.
CIRCULATION (2014)
Lipoprotein(a) mass: A massively misunderstood metric
Joseph P. McConnell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a) Prospective 15-Year Outcomes in the Bruneck Study
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
Michelle L. O'Donoghue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
ELEVATED LIPOPROTEIN(A) IS ASSOCIATED WITH WORSE OUTCOME IN TYPE 2 DIABETIC PATIENTS WITH SYMPTOMATIC CORONARY ARTERY DISEASE
Sung Woo Kwon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers
Benoit J. Arsenault et al.
PLOS ONE (2014)
Variations in Ischemic Heart Disease Burden by Age, Country, and Income The Global Burden of Diseases, Injuries, and Risk Factors 2010 Study
Andrew E. Moran et al.
GLOBAL HEART (2014)
Assessing Bias in Studies of Prognostic Factors
Jill A. Hayden et al.
ANNALS OF INTERNAL MEDICINE (2013)
Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease
Paul J. Nestel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Association between baseline lipoprotein (a) levels and restenosis after coronary stenting: Meta-analysis of 9 cohort studies
Shan-yu Qin et al.
ATHEROSCLEROSIS (2013)
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
Maya S. Safarova et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease Prospective Observational Multicenter Study
Josef Leebmann et al.
CIRCULATION (2013)
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes)
John J. Albers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Lipoprotein(a), Cardiovascular Disease, and Contemporary Management
Terry A. Jacobson
MAYO CLINIC PROCEEDINGS (2013)
Genetic Associations with Valvular Calcification and Aortic Stenosis
George Thanassoulis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) Trial
Koon K. Teo et al.
STROKE (2013)
Mechanisms of Lipoprotein(a) Pathogenicity Prothrombotic, Proatherosclerotic, or Both?
J. David Spence et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
Pia R. Kamstrup et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease The EPIC-Norfolk Prospective Population Study
Deepti Gurdasani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects The Atherosclerosis Risk in Communities (ARIC) Study
Salim S. Virani et al.
CIRCULATION (2012)
Lipoprotein(a), Interleukin-10, C-Reactive Protein, and 8-Year Outcome After Percutaneous Coronary Intervention
Isabella Kardys et al.
CLINICAL CARDIOLOGY (2012)
Lipid and Lipoprotein Biomarkers and the Risk of Ischemic Stroke in Postmenopausal Women
Jeffrey S. Berger et al.
STROKE (2012)
Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality
Ian Graham et al.
CURRENT CARDIOLOGY REPORTS (2012)
Usefulness of Lipoprotein (a) for Predicting Progression of Non-Culprit Coronary Lesions After Acute Myocardial Infarction
Hiroki Ikenaga et al.
CIRCULATION JOURNAL (2011)
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Stefania Lamon-Fava et al.
JOURNAL OF LIPID RESEARCH (2011)
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)
Stefano Volpato et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
Kåre Berg et al.
CLINICAL GENETICS (2010)
Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study)
H. Sone et al.
DIABETOLOGIA (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
Stephen J. Nicholls et al.
JOURNAL OF LIPID RESEARCH (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes
Jae Yeong Cho et al.
Korean Circulation Journal (2010)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: Analysis of data from the MEGA Study, a large randomized controlled trial
Shinichiro Uchiyama et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
All-Cause Mortality and Competing Risks of Fatal and Nonfatal Vascular Events in the Italian Longitudinal Study on Aging: Impact of Lipoprotein(a)
Vincenzo Solfrizzi et al.
REJUVENATION RESEARCH (2009)
Lipoprotein(a) levels and risk of future coronary heart disease
Anna Bennet et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Symptomatic peripheral arterial disease in women - Nontraditional biomarkers of elevated risk
Aruna D. Pradhan et al.
CIRCULATION (2008)
Lipoprotein(a) and cardiovascular disease in ethnic Chinese: The Chin-Shan Community Cardiovascular Cohort Study
Kuo-Liong Chien et al.
CLINICAL CHEMISTRY (2008)
Lipoprotein (a) and stroke - A meta-analysis of observational studies
Barbara Smolders et al.
STROKE (2007)
Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men -: A community-based study with long-term follow-up
Bernice Wiberg et al.
STROKE (2006)
Lipoprotein(a) and incident ischemic stroke - The atherosclerosis risk in communities (ARIC) study
Tetsuya Ohira et al.
STROKE (2006)
Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort
G Pernod et al.
KIDNEY INTERNATIONAL (2006)
Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients
CH Saely et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
T Pischon et al.
CIRCULATION (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes
I Shai et al.
DIABETOLOGIA (2005)
High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients
JC Longenecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction
AM Thogersen et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2004)
Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The physicians' health study
N Rifai et al.
CLINICAL CHEMISTRY (2004)
Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients
L Czupryniak et al.
OBESITY SURGERY (2004)
Lp(a) lipoprotein, vascular disease, and mortality in the elderly
AA Ariyo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting - The global evaluation of new events and restenosis after stent implantation study
MN Zairis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Lipoprotein(a) as a predictor of coronary heart disease: the PRIME Study
G Luc et al.
ATHEROSCLEROSIS (2002)
Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men
SF Agewall et al.
CLINICAL CARDIOLOGY (2002)
Hyperhomocyst(e)inemia and hemostatic factors: The atherosclerosis risk in communities study
PJ Schreiner et al.
ANNALS OF EPIDEMIOLOGY (2002)
Impairment of collateral formation in lipoprotein(a) transgenic mice - Therapeutic angiogenesis induced by human hepatocyte growth factor gene
R Morishita et al.
CIRCULATION (2002)
Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease: The Strong Heart Study
WY Wang et al.
ANNALS OF EPIDEMIOLOGY (2002)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men
M Seed et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study
PM Sweetnam et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2000)
Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
J Danesh et al.
CIRCULATION (2000)
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause
MG Shlipak et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
